The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...

Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...